Tarus receives clearance from the FDA to initiate clinical trial of TT-4
27 May 2021 //
BIOSPACE
Tarus Therapeutics Seeks To Initiate Clinical Trial of TT-4 (A2BR Antagonist)
28 Apr 2021 //
BIOSPACE
27 May 2021 //
BIOSPACE
28 Apr 2021 //
BIOSPACE